KRAS and colorectal carcinoma: Potential biomarkers for screening of CRC such as KRAS, TP53 and BAT26, among other genes, are being analyzed and considered as stool markers complementary to existing methods of cancer identification (Vaughn et al., 2011, Tian et al., 2013, Colucci, 2013).